Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Jan;99(1):53–58. doi: 10.1111/j.1476-5381.1990.tb14653.x

Pharmacokinetic-pharmacodynamic modelling of the anticonvulsant effect of oxazepam in individual rats.

J Dingemanse 1, R A Voskuyl 1, M W Langemeijer 1, I Postel-Westra 1, D D Breimer 1, H Meinardi 1, M Danhof 1
PMCID: PMC1917521  PMID: 2331575

Abstract

1. The purpose of this investigation was to examine in vivo drug-concentration anticonvulsant effect relationships of oxazepam in individual rats following administration of a single dose. 2. Whole blood concentration vs time profiles of oxazepam were determined following administration of doses of 4, 8 and 12 mg kg-1. The pharmacokinetics could be described by an open 2-compartment pharmacokinetic model. Following 12 mg kg-1 the values (mean +/- s.e., n = 11) of clearance and volume of distribution were 28 +/- 2 ml min-1 kg-1 and 2.6 +/- 0.31 kg-1, respectively, and were not significantly different from the values obtained at the other doses. 3. The anticonvulsant effect was quantitated by a new technique which allows repetitive determination of the convulsive threshold by direct cortical stimulation within one rat. Significant dose-dependent elevations of the seizure threshold were observed. 4. By pharmacokinetic-pharmacodynamic modelling, a log-linear relationship was found between concentration and anticonvulsant effect. Following 12 mg kg-1 the values (mean +/- s.e., n = 11) of the pharmacodynamic parameters slope and minimal effective concentration (Cmin) were 243 +/- 27 microA and 0.11 +/- 0.02 mg l-1, respectively and not significantly different from the values obtained at the other doses. 5. In a repeatability study the pharmacodynamic parameters were determined twice on two different occasions with an interval of two weeks in the same group of 11 rats. The inter-animal variability in the pharmacodynamic parameter slope was 46%, whereas the intra-animal variability was 24 +/- 18%.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
53

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braestrup C., Nielsen M. Anxiety. Lancet. 1982 Nov 6;2(8306):1030–1034. doi: 10.1016/s0140-6736(82)90059-9. [DOI] [PubMed] [Google Scholar]
  2. Dingemanse J., Danhof M., Breimer D. D. Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: an overview. Pharmacol Ther. 1988;38(1):1–52. doi: 10.1016/0163-7258(88)90101-5. [DOI] [PubMed] [Google Scholar]
  3. Dingemanse J., Sollie F. A., Breimer D. D., Danhof M. Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measure. J Pharmacokinet Biopharm. 1988 Apr;16(2):203–228. doi: 10.1007/BF01062261. [DOI] [PubMed] [Google Scholar]
  4. Dingemanse J., Thomassen D., Mentink B. H., Danhof M. Strategy to assess the role of (inter)active metabolites in pharmacodynamic studies in-vivo: a model study with heptabarbital. J Pharm Pharmacol. 1988 Aug;40(8):552–557. doi: 10.1111/j.2042-7158.1988.tb05301.x. [DOI] [PubMed] [Google Scholar]
  5. Francis R. J. ELSMOS--an extended least squares modelling system in FORTRAN IV for mini- or micro-computer implementation. Comput Programs Biomed. 1984 Feb-Apr;18(1-2):43–49. doi: 10.1016/0010-468x(84)90022-9. [DOI] [PubMed] [Google Scholar]
  6. Haigh J. R., Gent J. P., Calvert R. Plasma concentrations of clobazam and its N-desmethyl metabolite; protection against pentetrazol-induced convulsions in mice. J Pharm Pharmacol. 1984 Sep;36(9):636–638. doi: 10.1111/j.2042-7158.1984.tb04917.x. [DOI] [PubMed] [Google Scholar]
  7. Hariton C., Jadot G., Mesdjian E., Mandel P. Diazepam: kinetic profiles in various brain areas, plasma and erythrocytes after chronic administration in the rat. Eur J Drug Metab Pharmacokinet. 1985 Apr-Jun;10(2):105–111. doi: 10.1007/BF03189703. [DOI] [PubMed] [Google Scholar]
  8. Holford N. H., Sheiner L. B. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet. 1981 Nov-Dec;6(6):429–453. doi: 10.2165/00003088-198106060-00002. [DOI] [PubMed] [Google Scholar]
  9. Igari Y., Sugiyama Y., Sawada Y., Iga T., Hanano M. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model. J Pharmacokinet Biopharm. 1983 Dec;11(6):577–593. doi: 10.1007/BF01059058. [DOI] [PubMed] [Google Scholar]
  10. Klotz U., Antonin K. H., Bieck P. R. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. J Pharmacol Exp Ther. 1976 Oct;199(1):67–73. [PubMed] [Google Scholar]
  11. Klotz U. Estimation of the blood-plasma concentration ratio of diazepam in the rat. J Pharmacokinet Biopharm. 1985 Jun;13(3):347–348. doi: 10.1007/BF01065659. [DOI] [PubMed] [Google Scholar]
  12. Levy G. Kinetics of pharmacologic effects. Clin Pharmacol Ther. 1966 May-Jun;7(3):362–372. doi: 10.1002/cpt196673362. [DOI] [PubMed] [Google Scholar]
  13. SWINYARD E. A., RADHAKRISHNAN N., GOODMAN L. S. Effect of brief restraint on the convulsive threshold of mice. J Pharmacol Exp Ther. 1962 Dec;138:337–342. [PubMed] [Google Scholar]
  14. Sheiner L. B., Stanski D. R., Vozeh S., Miller R. D., Ham J. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther. 1979 Mar;25(3):358–371. doi: 10.1002/cpt1979253358. [DOI] [PubMed] [Google Scholar]
  15. Stanski D. R., Ham J., Miller R. D., Sheiner L. B. Pharmacokinetics and pharmacodynamics of d-tubocurarine during nitrous oxide-narcotic and halothane anesthesia in man. Anesthesiology. 1979 Sep;51(3):235–241. doi: 10.1097/00000542-197909000-00011. [DOI] [PubMed] [Google Scholar]
  16. Taylor S. M., Bennett G. D., Abbott L. C., Finnell R. H. Seizure control following administration of anticonvulsant drugs in the quaking mouse. Eur J Pharmacol. 1985 Nov 26;118(1-2):163–170. doi: 10.1016/0014-2999(85)90675-2. [DOI] [PubMed] [Google Scholar]
  17. Voskuyl R. A., Dingemanse J., Danhof M. Determination of the threshold for convulsions by direct cortical stimulation. Epilepsy Res. 1989 Mar-Apr;3(2):120–129. doi: 10.1016/0920-1211(89)90039-9. [DOI] [PubMed] [Google Scholar]
  18. WOOLLEY D. E., TIMIRAS P. S. Estrous and circadian periodicity and electroshock convulsions in rats. Am J Physiol. 1962 Feb;202:379–382. doi: 10.1152/ajplegacy.1962.202.2.379. [DOI] [PubMed] [Google Scholar]
  19. Wagner J. G. Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man. J Theor Biol. 1968 Aug;20(2):173–201. doi: 10.1016/0022-5193(68)90188-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES